In a human melanoma model, GILZ downregulation promoted the development of dormant stem-cell like states through FOXO3a activation, increased G0 cells, promoted tumorigenicity, and decreased expression of the differentiation marker tyrosinase. This evidence concerns the gene TSC22D3 and melanoma.